Tharimmune Reports Positive Phase 1 Data on TH104, its Lead Therapeutic ...

Tharimmune Reports Positive Phase 1 Data on TH104, its Lead Therapeutic ...

Related Keywords

United States ,Randy Milby ,Tharimmune Inc ,National Institute Of Diabetes ,National Institutes Of Health ,Nasdaq ,News Network ,European Regulatory ,Worst Itch Numerical Rating Scale ,National Institute ,Kidney Diseases ,National Institutes ,